Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1692 | Thyroid (non-cancer) | ICEECE2012

Vitamin E and selenium have a protective role in apoptosis induced by H2O2 in human thyrocytes

Yan S. , Shi S. , Wang Y. , Yu X. , Wang L.

Objective: To investigate the influence of vitamin E (VE) and selenium (Se) on apoptosis of human thyrocyte induced by H2O2.Methods: The human thyroid epithelium cells (TEC) from normal para-adenoma tissues of patients with thyroid adenoma resection were cultured. In prevention groups, vitamin E (50 μmol/l), selenium (10–7 mol/l) or serum-free medium was respectively added into thyrocytes of monolayer culture before H...

ea0011p303 | Diabetes, metabolism and cardiovascular | ECE2006

Insulin resistance syndrome (IRS) and non-alcoholic fatty liver disease (NAFLD) in obese children: influence of ethnic background, sex, age and family history of type 2 diabetes (T2DM)

Clough DL , Watson L , Cuisick C , Tetlow L , Amin RA , Clayton PE , Hall CM

Background: IRS consists of ≥3 of the following components: obesity (BMI >98th centile), abnormal insulin glucose homeostasis, hypertension, dyslipidaemia. Elevated serum alanine aminotransferase (ALT) is a marker of NAFLD.Objective: To define the prevalence of IRS and NAFLD in obese children referred to our centre.Methods: subjects: mean BMI-SDS +6 (+0.6 to +14), median age 13.4 years (3–19), female 66%, British Asi...

ea0024p47 | (1) | BSPED2010

Prevalence of congenital hypothyroidism (CHT) in infants presenting with prolonged jaundice

Ivison F , Gopalkothandapani S , Banerjee I , Tetlow L

Background: Among infants presenting with prolonged hyperbilirubinaemia there is anecdotal evidence that some babies who were Newborn Screening-negative for congenital hypothyroidism (CHT) have CHT diagnosed at the time of presentation with jaundice.Aims: To determine the prevalence of CHT in babies presenting with prolonged jaundice and to assess the predictive value of lowering the TSH cut-off for a screen-positive result on the ability to identify bab...

ea0088017 | Abstracts | BES2022

Prolactinomas: our experience in Liège

M Trebillod , L Vroonen , P Petrossians

Introduction: The true prevalence of clinically relevant pituitary adenomas has been reevaluated at 1/1064 of the population (1). Among them, prolactinomas represent the majority with a prevalence of 1/2000. They occur usually in females, aged 20–50 Y.O., and 80% are microadenomas. Nearly 5% of prolactinomas appear in a familial or genetic setting (MEN-1 or FIPA) (2). Cabergoline is proposed as the first line therapy and is usually efficient to normalize prolactin (PRL) l...

ea0026p90 | Female reproduction | ECE2011

Ovulation induction by metformin in lean and obese women with polycystic ovary syndrome

Popova P V , Ivanova L I , Karonova T L , Grineva E N

Introduction: Metformin is now one of the most common treatments for PCOS. However controversy exists about the usefulness of metformin in PCOS women with normal insulin sensitivity and normal weight. The aim of this study was to compare efficacy of metformin treatment for the purpose of restoration of ovulation in lean and obese women with polycystic ovary syndrome.Design: Thirty-six unovulatory women with PCOS (21 lean with mean body mass index (BMI) 2...

ea0024oc2.4 | Oral Communications 2 (Brief Communications) | BSPED2010

Morbidity and Mortality of Infants with Salt Wasting Congenital Adrenal Hyperplasia in an Unscreened Population

Hird B E , Patel L , Tobi S , Clayton P E

Due to the non-specificity of symptoms in male neonates affected by salt-wasting (SW) CAH, it is hypothesised that a proportion die prior to diagnosis in countries lacking a newborn screening (NBS) programme, such as the UK. The aim of this study was to analyse 17-hydroxyprogesterone (17-OHP) in stored NBS blood spot samples, to detect undiagnosed cases of CAH. Samples were retrieved from storage for neonates who were born between 1994 and 2006, who subsequently died before 7 ...

ea0016p86 | Bone and calcium | ECE2008

Vitamin D deficiency and supplementation in pregnancy, a randomised study of 180 women in four ethnic groups

Yu CYH , Newton L , Sethi M , Teoh TG , Robinson S

Objective: To determine the vitamin D status in pregnancy and to evaluate the effects of daily and of single-dose vitamin D supplementation.Design: A prospective randomised study, in an inner city ante-natal clinic.Participants: Forty-five women in each of the four ethnic groups, Indian Asians, Middle Eastern, Black and Caucasian, were studied (incomplete delivery data at time of submission).Intervention: Wom...

ea0029p1031 | Male Reproduction | ICEECE2012

Decreased osteoprotegerin levels during testosterone therapy in ageing men were associated with changed distribution of regional fat

Glintborg D. , Frederiksen L. , Hougaard D. , Brixen K. , Rasmussen L. , Andersen M.

Objective: The cardiovascular effects of testosterone treatment are debated. Osteoprotegerin (OPG) is an independent marker of cardiovascular risk. We investigated the effect of testosterone therapy on OPG levels in ageing men with low normal bioavailable testosterone levels.Design: A randomized, double-blinded, placebo-controlled study of six months testosterone therapy (gel) in 38 men aged 60–78 years with bioavailable testosterone <7.3 nmol/l...

ea0026p707 | Diabetes complications | ECE2011

Adrenocortical hypofunction in patients with diabetes mellitus type 1

Simunkova K , Vondra K , Hill M , Duskova M , Kriz L , Starka L

This work aimed at gathering own data on adrenal response to low-dose Synacthen test, CRH test and about periferal metabolism of cortisol in autoimmune type 1 diabetics with onset in adults. Seventy diabetics were investigated; age 44±10 years (mean±S.D.), age at diagnosis 28.5±10 years, disease duration 15±8 years, BMI 24.5±2.7 kg/cm2, HbA1c 7.2±1.2%. The study was approved by the Ethical Committee. Adrenal reserve was t...

ea0029p1678 | Thyroid (non-cancer) | ICEECE2012

Optimal timing of thyroxine dose adjustment for treating patients with primary hypothyroidism: what is the estimated time required to reach stable TSH levels?

Kohler S. , Senn O. , Saleh L. , Wass J. , Schmid C.

Aim: Serum TSH is the target value by which adequate thyroid hormone supply can easily be monitored in patients with primary hypothyroidism. It is controversial when TSH should be measured before thyroxine dose adjustments are made, 4–8 weeks are recommended. To define the time when dose adjustments of thyroxine are feasible more clearly, we looked at the time required to reach stable TSH levels.Methods: We prospectively studied a case series of pat...